← back to search

Nyanda Elias Ntinginya

Liverpool School of Tropical Medicine · GB
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Medicine, Tuberculosis, Sputum, Virology, Biology, and Tanzania.
h-index
citations
1,221
works
20
NIH funding
primary concept
email

Recent publications

Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial
The Lancet Infectious Diseases 2025cited by 25position: middledoi
Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial
The Lancet Infectious Diseases 2025cited by 16position: middledoi
Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial
The Lancet Infectious Diseases 2025cited by 15position: middledoi
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy
Nature Immunology 2025cited by 4position: middledoi
The pattern change of hepatitis B virus genetic diversity in Northwestern Tanzania
Scientific Reports 2025cited by 4position: middledoi
Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South Africa
Open Forum Infectious Diseases 2024cited by 12position: middledoi
Study protocol: a pragmatic, cluster-randomized controlled trial to evaluate the effect of implementation of the Truenat platform/MTB assays at primary health care clinics in Mozambique and Tanzania (TB-CAPT CORE)
BMC Infectious Diseases 2024cited by 7position: middledoi
Detection of Bombali Virus in a Mops condylurus Bat in Kyela, Tanzania
Viruses 2024cited by 5position: middledoi
Diagnostic accuracy of a three-gene Mycobacterium tuberculosis host response cartridge using fingerstick blood for childhood tuberculosis: a multicentre prospective study in low-income and middle-income countries
The Lancet Infectious Diseases 2023cited by 46position: middledoi
Rapid and Accurate Diagnosis of Pediatric Tuberculosis Disease: A Diagnostic Accuracy Study for Pediatric Tuberculosis
The Pediatric Infectious Disease Journal 2023cited by 21position: middledoi
Dynamics and durability of HIV-1 neutralization are determined by viral replication
Nature Medicine 2023cited by 17position: middledoi
Unravelling patient pathways in the context of antibacterial resistance in East Africa
BMC Infectious Diseases 2023cited by 14position: middledoi
Kiwira Virus, a Newfound Hantavirus Discovered in Free-tailed Bats (Molossidae) in East and Central Africa
Viruses 2022cited by 14position: middledoi
Early risk assessment in paediatric and adult household contacts of confirmed tuberculosis cases by novel diagnostic tests (ERASE-TB): protocol for a prospective, non-interventional, longitudinal, multicountry cohort study
BMJ Open 2022cited by 9position: middledoi
Diagnosis of paediatric TB using Xpert<sup>®</sup> MTB/RIF Ultra on fresh respiratory samples
The International Journal of Tuberculosis and Lung Disease 2022cited by 8position: middledoi
Comparing accuracy of lipoarabinomannan urine tests for diagnosis of pulmonary tuberculosis in children from four African countries: a cross-sectional study
The Lancet Infectious Diseases 2020cited by 43position: middledoi
Regional Variation of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales, Fluoroquinolone-Resistant Salmonella enterica and Methicillin-Resistant Staphylococcus aureus Among Febrile Patients in Sub-Saharan Africa
Frontiers in Microbiology 2020cited by 26position: middledoi
TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB – a study protocol
BMC Pulmonary Medicine 2019cited by 71position: middledoi
Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages
Nature Genetics 2016cited by 479position: middledoi
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
The Lancet Infectious Diseases 2016cited by 385position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Norbert Heinrich · University of London4 papers (2020–2023) · 3 papers (2020–2024)Christof Geldmacher · University of Regensburg3 papers (2019–2023)Beate Kampmann · Harvard University2 papers (2019–2022)Detlev H. Krüger · Charité - Universitätsmedizin Berlin2 papers (2022–2024)Denise Banze · LMU Klinikum2 papers (2022–2023)Sabrina Weiß · Robert Koch Institute2 papers (2022–2024)Uzochukwu Egere · Liverpool School of Tropical Medicine2 papers (2022–2023) · 2 papers (2020–2022) · 2 papers (2022–2024)Fabian H. Leendertz · Institut Pasteur2 papers (2022–2024)Michael Höelscher · Fraunhofer Institute for Translational Medicine and Pharmacology2 papers (2019–2022)Celso Khosa · Liverpool School of Tropical Medicine2 papers (2022–2023)Issa Sabi · London School of Hygiene & Tropical Medicine2 papers (2022–2023) · 1 papers (2024–2024)Britta Groendahl · Johannes Gutenberg University Mainz1 papers (2025–2025) · 1 papers (2024–2024)Kathrin Held · University of Regensburg1 papers (2022–2022)Aurélia Souares · University Hospital Heidelberg1 papers (2020–2020)Boris Klempa · Biomedical Research Center of the Slovak Academy of Sciences1 papers (2022–2022)